Systems, devices, and methods including infection-fighting and monitoring shunts
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-037/00
A61N-005/06
A61L-002/00
A61L-002/08
A61L-002/14
A61N-001/20
A61M-027/00
A61B-005/00
A61B-005/145
A61M-005/142
A61N-001/372
A61N-001/378
A61N-001/40
A61N-005/02
A61N-005/10
A61N-007/00
A61B-005/053
A61B-005/1459
A61B-005/1473
A61B-018/20
출원번호
US-0800798
(2010-05-21)
등록번호
US-9687670
(2017-06-27)
발명자
/ 주소
Dacey, Jr., Ralph G.
Hyde, Roderick A.
Ishikawa, Muriel Y.
Kare, Jordin T.
Leuthardt, Eric C.
Myhrvold, Nathan P.
Rivet, Dennis J.
Smith, Michael A.
Sweeney, Elizabeth A.
Tegreene, Clarence T.
Wood, Jr., Lowell L.
Wood, Victoria Y. H.
출원인 / 주소
Gearbox, LLC
인용정보
피인용 횟수 :
0인용 특허 :
153
초록
Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection.
대표청구항▼
1. A shunt assembly, comprising: a body structure defining one or more fluid-flow passageways configured to receive a biological fluid of a biological subject;a sensor component for detecting an infectious agent proximate to the body structure;a sterilizing energy emitter configured to emit a steril
1. A shunt assembly, comprising: a body structure defining one or more fluid-flow passageways configured to receive a biological fluid of a biological subject;a sensor component for detecting an infectious agent proximate to the body structure;a sterilizing energy emitter configured to emit a sterilizing energy stimulus to the biological fluid or to the infectious agent proximate to the body structure; andmeans for reflecting at least a portion of the emitted energy stimulus within an interior of at least one of the one or more fluid-flow passageways. 2. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes one or more energy emitters configured to emit the energy stimulus to an interior at least one of the one or more fluid-flow passageways, and an optical material that internally reflects at least a portion of an emitted energy stimulus present within an interior of at least one of the one or more fluid-flow passageways. 3. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes an optical material that internally reflects at least a portion of an emitted energy stimulus within an interior of at least one of the one or more fluid-flow passageways, without substantially permitting the transmission of the emitted energy stimulus through an exterior of the body structure. 4. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes an optical material that internally directs at least a portion of an emitted energy stimulus along a substantially lateral direction of at least one of the one or more fluid-flow passageways. 5. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes a reflective surface capable of reflecting at least about 50 percent of an energy stimulus emitted by the one or more energy emitters that impinges on the reflective surface. 6. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes a reflective surface that is reflective at a first wavelength and transmissive at a second wavelength different from the first wavelength. 7. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes one or more internally reflective components configured to manage a delivery of light to a biological fluid received within the one or more fluid-flow passageways, and to manage a collection of reflected light from the biological fluid. 8. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes an optical component that directs a first portion of an emitted energy stimulus along a substantially lateral direction in one or more regions of at least one of the one or more fluid-flow passageways and an optical component that directs a second portion of the emitted energy stimulus along a substantially longitudinal direction in one or more regions of at least one of the one or more fluid-flow passageways. 9. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes a first optical component configured to direct at least a portion of an emitted energy stimulus along a substantially lateral direction in a first region of at least one of the one or more fluid-flow passageways and a second optical component configured to direct at least a portion of the emitted energy stimulus along a substantially lateral direction in a second region of the one or more fluid-flow passageways, the second region different from the first region. 10. The shunt assembly of claim 1, wherein the means for reflecting at least a portion of an emitted energy stimulus includes a first optical component that directs at least a portion of an emitted energy stimulus along a substantially longitudinal direction in a first region of at least one of the one or more fluid-flow passageways and a second optical component that directs at least a portion of the emitted energy stimulus along a substantially longitudinal direction in a second region of the one or more fluid-flow passageways, the second region different from the first region. 11. The shunt assembly of claim 1, wherein at least a portion of the body structure is configured to sufficiently internally reflect at least a portion of an emitted energy stimulus to generate an evanescent electromagnetic field across one or more regions of the body structure. 12. The shunt assembly of claim 1, wherein at least a portion of the body structure is configured to sufficiently internally reflect at least a portion of an emitted energy stimulus to cause an evanescent electromagnetic field to emanate from at least a portion of the body structure. 13. The shunt assembly of claim 1, wherein at least a portion of the body structure is configured to internally reflect at least a portion of an emitted energy stimulus within an interior of at least one of the one or more fluid-flow passageways. 14. The shunt assembly of claim 1, wherein at least a portion of the body structure is configured to totally internally reflect at least a portion of an emitted energy-stimulus propagated within an interior of at least one of the one or more fluid-flow passageways. 15. The shunt assembly of claim 1, wherein the infectious agent is in a biofilm. 16. The shunt assembly of claim 1, wherein the sensor component is configured to perform a real-time comparison of a measurand associated with a biological sample proximate one or more regions of at least one surface of the implantable device to stored reference data. 17. The shunt assembly of claim 1, wherein the sensor component is configured to detect at least one physiological characteristic associated with an infectious agent. 18. The shunt assembly of claim 1, further comprising a controller operably coupled to the sensor component and to the sterilizing energy emitter, the controller configured to automatically control at least one characteristic associated with sterilizing energy stimulus. 19. A shunt assembly, comprising: a body structure defining one or more fluid-flow passageways configured to receive a biological fluid of a biological subject; at least a portion of the body structure configured to reflecting at least a portion of an emitted energy stimulus within the interior of at least one of the one or more fluid-flow passageways;a sensor component for detecting an infectious agent proximate to the body structure; andone or more energy emitters configured to emit the energy stimulus to an interior at least one of the one or more fluid-flow passageways;wherein at least a portion of a body structure defining the one or more fluid-flow passageways includes a reflective surface capable of reflecting at least about 50 percent of an energy stimulus emitted by the one or more energy emitters that impinges on the reflective surface. 20. The shunt assembly of claim 19, wherein the at least a portion of the body structure is configured to laterally internally reflect or longitudinally internally reflect electromagnetic radiation transmitted within the interior of at least one of the one or more fluid-flow passageways. 21. The shunt assembly of claim 19, further comprising: one or more optical materials forming at least a portion of a body structure defining the one or more fluid-flow passageways, the one or more optical materials configured to limit an amount of the energy stimulus that can traverse within the one or more fluid-flow passageways and through an outer surface of the body structure. 22. The shunt assembly of claim 19, further comprising: one or more optical materials on at least a portion of a body structure defining the one or more fluid-flow passageways to internally reflect at least a portion of an emitted energy stimulus from the one or more energy emitters into an interior of at least one of the one or more fluid-flow passageways. 23. The shunt assembly of claim 19, further comprising: at least one outer internally reflective coating on a body structure defining the one or more fluid-flow passageways. 24. The shunt assembly of claim 19, further comprising: at least one inner internally reflective coating on a body structure defining the one or more fluid-flow passageways. 25. The shunt assembly of claim 19, wherein at least one of the one or more fluid-flow passageways includes a surface configured to laterally internally reflect or longitudinally internally reflect electromagnetic radiation transmitted there through. 26. The shunt assembly of claim 19, wherein at least a portion of a body structure defining the one or more fluid-flow passageways includes a reflective surface that is reflective at a first wavelength and transmissive at a second wavelength different from the first wavelength. 27. The shunt assembly of claim 19, wherein at least one of the one or more fluid-flow passageways includes one or more internally reflective components configured to manage a delivery of light to a biological fluid received within the one or more fluid-flow passageways, and to manage a collection of reflected light from the biological fluid. 28. The shunt assembly of claim 19, wherein at least one of the one or more fluid-flow passageways includes at least one of an outer surface and an inner surface that is reflective to at least one of electromagnetic energy, ultrasonic energy, and thermal energy. 29. The shunt assembly of claim 19, wherein the infectious agent is in a biofilm. 30. The shunt assembly of claim 19, wherein the sensor component is configured to perform a real-time comparison of a measurand associated with a biological sample proximate one or more regions of at least one surface of the implantable device to stored reference data. 31. The shunt assembly of claim 19, wherein the sensor component is configured to detect at least one physiological characteristic associated with an infectious agent. 32. The shunt assembly of claim 19, further comprising a controller operably coupled to the sensor component and to at least one of the one or more energy emitters, the controller configured to automatically control at least one characteristic associated with sterilizing energy stimulus.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (153)
Menon I. Aravindakshan,CAX ; Haberman Herbert F.,CAX, 33 Lipomelanin sunscreen composition.
Seeberger,Michael; Vanderlinde,Scott; Kalgren,James; Lindh,Par; Larsen Kelly,Kristine M.; Lanz,Mitchell; Thompson,Jeffrey M.; Dyjach,John A., Adaptive software configuration for a medical device.
Smith, Patrick J.; Jones, Jason A.; McGonagle, Kevin A., Apparatus and method for activation of a digital signal processor in an idle mode for interprocessor transfer of signal groups in a digital signal processing unit.
Snaper Alvin A. (2800 Cameo Cir. Las Vegas NV 89107) Gelbaum Bernard R. (127 Ruskin Rd. Buffalo NY 14226) Gelbaum Daniel (48 Bellevue San Rafael CA 94901), Bio-operable power source.
Panero,Stefania; Abbati,Gianluca; Renier,Davide; Crescenzi,Vittorio, Electrically conductive polymeric biomaterials, the process for their preparation and the use thereof in the biomedical and healthcare field.
Oksman Henry C. (140 Morris La. Scarsdale NY 10583) Eisner Joseph (219 E. 32nd St. New York NY 10016), Electrochemical contact lens disinfection and neutralization system.
Nova Michael P. ; Parandoosh Zahra ; Senyei Andrew E. ; Xiao Xiao-Yi ; David Gary S. ; Satoda Yozo ; Zhao Chanfeng ; Potash Hanan, Matrices with memories and uses thereof.
Wilk Peter J. (185 West End Ave. New York NY 10023) Tiefenbrun Jonathan (62 Country Rd. Mamaroneck NY 10543), Method and apparatus for catheter sterilization.
Frank R. Prosl ; Hans-Dietrich Polaschegg AT; Brian K. Estabrook ; Klaus Sodemann DE, Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device.
Khalil,Omar S.; Yeh,Shu jen; Kantor,Stanislaw; Hanna,Charles F.; Shain,Eric B., Method for optical measurements of tissue to determine disease state or concentration of an analyte.
Silver Jerry (Lyndhurst OH) Smith George M. (Cleveland OH) Jacobberger James W. (Chesterland OH), Method of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use o.
John T. Santini, Jr. ; Charles E. Hutchinson ; Scott A. Uhland ; Michael J. Cima ; Robert S. Langer ; Dennis Ausiello, Microfabricated devices for the delivery of molecules into a carrier fluid.
Santini, Jr., John T.; Sheppard, Jr., Norman F.; Young, Chung Chang; Langer, Robert S., Microfabricated devices for the storage and selective exposure of chemicals and devices.
Boni Lawrence T. ; Janoff Andrew S. ; Minchey Sharma R. ; Perkins Walter R. ; Swenson Christine E. ; Ahl Patrick L. ; Davis Thomas S., Pharmaceutical compositions containing interdigitation-fusion liposomes and gels.
Connelly,Patrick R.; Foster,Thomas H.; Weiner,Michael L.; Custer,Andrew W., Process for identifying cancerous and/or metastatic cells of a living organism.
Schulman Joseph H. (Santa Clarita CA) Mann Alfred E. (Beverly Hills CA) Byers Charles L. (Canyon Country CA) Love Jack W. (Santa Barbara CA), Replaceable catheter system for physiological sensors, stimulating electrodes and/or implantable fluid delivery systems.
Wong Tai-Ting (7th Fl. ; No. 320-3 ; Shin Pai Rd. ; Sec. 2 Taipei) Lee Liang-Shong (Taipei) Niu Gregory C. (Taipei TWX), Shunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus.
Brennan, Anthony B; Baney, Ronald H.; Carman, Michelle L.; Estes, Thomas G.; Feinberg, Adam W.; Wilson, Leslie H.; Schumacher, James F., Surface topographies for non-toxic bioadhesion control.
Currie, John F.; Paranjape, Makarand; Peck, Carl C.; White, Robert; Schneider, Thomas W., Systems and methods for monitoring health and delivering drugs transdermally.
Greenfeld Albert R. (31430 Glenbridge Rd. Westlake Village CA 91361) Reis Herbert (Thousand Oaks CA) Tittmann Bernhard R. (Thousand Oaks CA), Ultrasonic self-cleaning catheter system for indwelling drains and medication supply.
Pennell Phillip E. (Denver CO) Blackmore John M. (Redwood City CA) Allen Mark D. (Lakewood CO), Viscoelastic fluid for use in spine and general surgery and other surgery and therapies and method of using same.
Kittrell Carter (Cambridge MA) Willett Robert L. (Billings MT) de los Santos-Pacheco Cynthia (Cambridge MA) Kenny Leo T. (New Bedford MA) Feld Michael S. (Waban MA), Visible fluorescence spectral diagnostic for laser angiosurgery.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.